Cargando…
Immune-based therapies in the management of multiple myeloma
Multiple myeloma (MM) is a clonal plasma cell malignancy affecting a predominantly elderly population. The continued development of newer therapies with novel mechanisms of action has reshaped the treatment paradigm of this disorder in the last two decades, leading to a significantly improved progno...
Autores principales: | Zanwar, Saurabh, Nandakumar, Bharat, Kumar, Shaji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443188/ https://www.ncbi.nlm.nih.gov/pubmed/32829378 http://dx.doi.org/10.1038/s41408-020-00350-x |
Ejemplares similares
-
Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies
por: Larsen, Jeremy T., et al.
Publicado: (2015) -
Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Ho, Matthew, et al.
Publicado: (2022) -
Extramedullary disease in multiple myeloma
por: Bansal, Radhika, et al.
Publicado: (2021) -
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
por: Karam, Dhauna, et al.
Publicado: (2021) -
Efficacy of Bortezomib as First-Line Treatment for Patients with Multiple Myeloma
por: Painuly, Utkarsh, et al.
Publicado: (2013)